Our CPS team just returned from the NASP (National Association of Specialty Pharmacies) Annual Meeting in Washington D.C. where CPS CEO, Joe Morse, spoke on a panel with other industry experts on technology and how important interoperability and reporting is. This conference marked the first time ever that CPS submitted an abstract to the association and received approval to have a poster presentation at the conference. The poster was created based on a study that CPS completed on Rheumatoid Arthritis adherence and outcomes improvement. CPS received FIRST PLACE in the specialty pharmacy technology provided products and services group.  A HUGE CONGRATS and THANK 

YOU to our customers and team members that were involved in this study. The Poster Presentation is titled "Technology-enabled Specialty Pharmacy Utilization of the Routine Assessment of Patient Index Data (RAPID3) to Monitor and Enhance Outcomes of Rheumatoid Arthritis (RA) Patient- A Retrospective Review". 

To view a press release shared by NASP, please click here.